Tourmaline Bio Inc (TRML)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Operating Expenses | 89,732 | 45,409 | 19,701 | 47,507 | 22,684 |
| Operating Income | -89,732 | -45,409 | -19,701 | -47,507 | -22,684 |
| Other Income | 16,522 | 3,285 | 0 | -326 | -23 |
| Pre-tax Income | -73,210 | -42,124 | -19,701 | -47,833 | -22,707 |
| Net Income Continuous | -73,210 | -42,124 | -19,701 | -47,833 | -22,707 |
| Net Income | $-73,210 | $-42,124 | $-19,701 | $-47,833 | $-22,707 |
| EPS Basic Total Ops | -2.89 | -8.87 | -22.46 | -16.40 | -34.00 |
| EPS Basic Continuous Ops | -2.89 | -8.87 | -22.46 | -16.42 | -33.97 |
| EPS Diluted Total Ops | -2.89 | -8.87 | -22.46 | -16.40 | -34.00 |
| EPS Diluted Continuous Ops | -2.89 | -8.87 | -22.46 | -16.42 | -33.97 |
| EPS Diluted Before Non-Recurring Items | -2.89 | -8.87 | -17.90 | -16.40 | N/A |
| EBITDA(a) | $-97,287 | $-45,898 | $-19,695 | $-46,457 | $-22,142 |